The groundbreaking, minimally invasive thoracic branch endoprosthesis, preserved brain and arm blood flow, sparing the patient from major open‑chest operation and enabling faster recovery
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, is pioneering a more inclusive and empowering healthcare environment for People of Determination (POD) by becoming the first healthcare network in the region to join the Hidden Challenges Sunflower program and introducing portable hearing loop systems across its facilities.
Explore MoreHealthpoint, a leading surgical hospital and part of M42’s world-class portfolio, has partnered with Osstem Implant, the world’s third-largest dental implant manufacturer based in South Korea, to introduce cutting-edge Korean dental technology to its patients in Abu Dhabi.
Explore MoreCleveland Clinic Abu Dhabi introduces innovative Artisse Intrasaccular Flow Modulator for stroke treatment.
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology, and genomics, is pleased to announce the appointment of Dimitris Moulavasilis as the company’s new Group Chief Executive Officer, effective immediately. This change comes as Hasan Jasem Al Nowais transitions from his role to continue as a member of M42’s Board after a long and successful tenure leading M42 and, previously, Mubadala Health.
Explore MoreM42 signed a strategic partnership with Toshiba to introduce the first heavy-ion therapy in the UAE and the Middle East
Explore MoreIn a sign of its ambition to expand its foothold in genomics and grow its contribution to global genomics diversity, M42 and Uzbekistan’s Ministry of Health have signed a Memorandum of Understanding (“MoU”) to collaborate and explore opportunities for strategic partnerships on the Uzbek Genome Program.
Explore MoreM42, a global health leader powered by artificial intelligence (AI) and technology, has called on healthcare, technology and academic leaders to join it in the battle against disease by shifting the focus of the healthcare industry from sickness to prevention.
Explore MoreBahrain Mumtalakat Holding Company (Mumtalakat), the sovereign wealth fund of the Kingdom of Bahrain, has announced
Explore MoreM42, a leading global health-tech powerhouse, is proud to unveil its lineup of top global health experts to convene on the M42 Main Stage at the inaugural Abu Dhabi Global Healthcare Week 2024 (ADGHW).
Explore MoreM42, a first-of-its-kind tech-enabled global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine.
Explore MoreMore than 300 healthcare professionals attended the second edition, following last year’s inaugural event which welcomed 180 par...
The groundbreaking, minimally invasive thoracic branch endoprosthesis, preserved brain and arm blood flow, sparing the patient f...
M42, a global health leader powered by artificial intelligence (AI), technology and genomics, is pioneering a more inclusive and...
Healthpoint, a leading surgical hospital and part of M42’s world-class portfolio, has partnered with Osstem Implant, the world’s...
The pioneering transplant was performed on a 40-year-old patient from Jordan, diagnosed with colon cancer in 2019
Imperial College London Diabetes & Endocrine Centre unveils updated brand identity to reflect a fuller spectrum of endocrine car...
